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A chymotrypsin-like protease was purified to homogeneity from human tonsils by a series of chromatographic procedures. The purified enzyme 
gave a single protein band with an apparent molecular mass of 30 kDa on SDS-PAGE. The sequence of the first 21 ammo acids at the N-termmus 
of the enzyme was determmed. A cDNA for the enzyme was cloned by PCR amplification from extracted tonsillar mRNA using a supposed 
N-terminal oligonucleotide primer and a conserved C-terminal primer of the chymase family. The deduced ammo acid sequence of the isolated 
clone was identical to that of human chymase in connective tissue-type mast cells from heart except for a Ser instead of a Cys at the N-terminal 
7th position. 
Chymase; Human tonsil, cDNA clomng: Ammo acid sequence 
1. INTRODUCTION 
Human mast cells play a crucial role in allergic in- 
flammation. A chymotrypsin-like protease, chymase, in 
the histamine granules of mast cells has been postulated 
to play a role in the stimulation-secretion coupling or 
the exocytotic process of histamine granules induced by 
IgE [l-3]. Immunohistochemical studies have demon- 
strated the presence of two types of mast cells, (i) con- 
nective tissue mast cells with chymase in the skin and 
submucosa of the gut and (ii) mucosal mast cells lacking 
chymase in the lung and gut mucosa [4]. Human chy- 
mase has been purified from the heart [5] and skin [6] 
and cDNA for human heart chymase has been cloned 
[7], although dispersed mast cells from these human 
organs have not been prepared. 
In order to study the mechanism of degranulation 
from human mast cells and to identify the inhibitors of 
degranulation as anti-allergic drugs, human mast cells 
prepared from operatively removed tonsils and ade- 
noids are particularly useful [3]. At present, however. 
little is known about the chymotrypsin-like protease in 
human tonsillar mast cells. We therefore purified this 
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enzyme from human tonsils and cloned the cDNA by 
PCR amplification. In this paper, we are the first to 
describe the amino acid sequence of the chymotrypsin- 
like protease from human tonsils, which is classified 
into the family of human chymases. 
2. MATERIALS AND METHODS 
2.1 Materzals 
Surgically removed tonstls from children (34 g/piece) were studied. 
G2000SW-XL and a Heparin SPW HPLC column were obtained from 
Tosoh Inc.. Tokyo. Japan. The Aquapore RP-300 7C8 reverse-phase 
HPLC column was from Applied Biosystems Inc., USA. Suc-Leu- 
Leu-Val-Tyr-MCA (Sue-LLVY-MCA) was from Protein Research 
Foundation, Osaka, Japan. Membranes were from Amicon Inc., 
USA. The primers were synthesized on an Applied Btosystems 391 
PCR-mate. Isolated DNAs were sequenced using an Applied Biosys- 
terns model 370A DNA Sequencer. All other materials were of com- 
mercial grade. 
2.2. Enzyme und protezn ussuys 
The activity of enzymes was measured wtth Sue-LLVY-MCA in 0.1 
M phosphate buffer, pH 8.0 [S]. The hydrolyzed product, 7-amino-4- 
methyl-coumarm, was detected by fluorescence spectrophotometry 
(Hitachi Inc., Japan) with emission at 460 nm and exitation at 370 nm. 
One unit of enzyme was defined as the amount hydrolyzing 1 firno 
of the substrate per min. The protein concentration was determined 
by the Lowry method [9]. 
2.3. Enzyme purzfcation 
The following steps were all performed at 4°C. The human tonsils 
(60 g) were minced and homogenized with 600 ml of 0.1 M phosphate 
buffer. pH 8.0, in a Polytron for 5 min, and the homogenates were 
centrifuged at 22,000 x g for 30 mm. This procedure was repeated 
twice to remove soluble cellular proteins. A chymotrypsin-like pro- 
tease that hydrolyzed Sue-LLVY-MCA was extracted by homogeniza- 
tion with 600 ml of 0.1 M phosphate buffer, pH 8.0, containing 2 M 
NaCl and 5% ammomum sulfate. The extract was centrifuged at 
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27,000 x g for 20 min and the supernatant was ultrafiltrated through 
an Amicon YMIOO membrane. The filtrate was concentrated on an 
Amicon YMlO and subjected to gel-permeation HPLC on a 
G2000SW-XL column (6.0 x 300 mm), pre-equilibrated with the en- 
zyme extraction buffer. The enzyme was eluted with an apparent 
molecular mass of about 30 kDa. The active fractions were pooled and 
concentrated by Amicon YMlO. The concentrated samples was di- 
luted 20 times with 2.5 mM Tris-HCl buffer, pH 8.5, to adjust the NaCl 
concentration at 0.1 M. The diluted fractton was applied to a Heparin 
SPW HPLC column (7.5 x 75 mm) and the column was washed with 
2.5 mM Tris-HCI. pH 8.0, 0 1 M NaCl until the absorbance of the 
eluate at 280 nm had returned to the baseline. Then the enzyme was 
eluted with a linear gradient of 0.1-2 0 M NaCl in 25 mM Tris-HCI 
buffer, pH 8.0. The active fractions that eluted at about 1.2 M NaCl 
were pooled, concentrated and desalted with 25 mM Trts-HCl, pH 8.0. 
contaming 0.1 M NaCl. on the Amicon YMlO. At this step. the 
enzyme migrated as a single protein band with an apparent molecular 
mass of 30 kDa on SDS-PAGE under reducmg conditions followed 
by staming with Coomassie brilliant blue R-250 (data not shown). An 
ahquot of the final preparation was applied to an Aquapore RP-300 
reverse-phase HPLC column to test the purity and to remove a minor 
contaminant. The column was equilibrated with 0.05% TFA and the 
enzyme was eluted with a 50 min linear gradient of 0.05% TFA- 
0.075% TFA containing 70% acetonitrile at a flow rate of 0.4 mllmin 
and 50°C. The active fraction eluted at 42 mm. was concentrated on 
the Amicon YM 10 and the N-termmus was sequenced on an Applied 
Biosystems model 470 gas-phase protein sequencer 
The enzyme gene was cloned by PCR [lo]. The 5’ primer was 
selected from the deduced nucleotide sequence of the N-terminal 8 
ammo acid residues. The 3’ primer was designed to match the con- 
served region in the human chymase family [7]. The mRNA was 
prepared from fresh tonsils with guanidm isothiocyanate [Ill. The 
mRNA was first transcribed to DNA usmg reverse transcriptase and 
an ohgo-dT primer. then the resulting single-stranded cDNA was 
amplified usmg the sense strand, ATCATCGGGGGCACAG- 
AATCCAAG. and the antisense-strand. TAATTTGCCTGCA- 
GGATCTGGTT. A 681 bp product was obtained, subcloned mto 
M13mplO at the HincII site. then sequenced [12]. 
3. RESULTS AND DISCUSSION 
3.1. Pur$cation of a ch!wotrypisin-like protease from 
human tonsils 
The results of a typical enzyme purification are sum- 
marized in Table I. Starting from 60 g of human tonsils, 
33 pg of purified enzyme was obtained at 2.2% yield in 
activity with a 101 ,OOO-fold purification from the crude 
extract filtered through Amicon YM 100. A chymotryp- 
sin-like protease in human tonsils was extracted with a 
Table I 
Purification of chymotrypsin-like protease from human tonsils 
Purification step Total Total Activity Specific Recovery 
volume protein (mu)” activity (%) 
(ml) (mg) (mU/mg) 
1. Amicon YMlOO 600 600 150.000 250 100 
2. Amicon YMlO 4.5 22.5 23,900 1,060 16 
3. G2000 SW-XL 1.6 1.5 5,980 3.990 4.0 
4. Heparm 5PW 0.2 0.033 3.340 101.000 2.2 
“Units of Sue-LLVY-MCA hydrolyzing activity 
120 
123456 
Fig. 1. Agarose gel electrophoresis of PCR products from tonsillar 
mRNA. Tonsillar mRNA was reverse transcribed usmg reverse tran- 
scriptase XL (Life Science Co , USA) The PCR reaction proceeded 
for 30 cycles under conditions of denaturation at 94°C for 1 mm. 
annealing at 55°C for 2 mm and extention at 72°C for 3 min. using 
the 5’ primers ATC AK GGG GGC ACA GAA TCC AAG (DNA 1) 
and ATC ATC GGG GGC ACA GAA TGC AAG (DNAZ). and the 
3’ primers TTA ATT TGC CTG CAG CAT CTG GTT (DNA3) and 
TA ATG GGA GAT TCG GGT GAA GAC (DNA4). Lane 1. 
RDNA-HI?~~III fragments; lane 2. @XI74DNA~HaeIlI fragments: 
lane 3, products of DNA1 and 3; lane 4. DNA1 and 4; lane 5, DNA2 
and 3: lane 6. DNA2 and 4; on 0.8% agarose. 
high concentration of salt (2.0 M NaCl and 5% ammo- 
nium sulfate) after washing the homogenate with 100 
mM potassium phosphate buffer. pH 8.0. This washing 
step should remove other neutral serine proteases, but 
not the enzyme. The enzyme had high affinity for hepa- 
rin, eluting at 1.2 M NaCl from a heparin-Sepharose 
column, resulting in a 404-fold increase in specific activ- 
ity. The affinity of the enzyme for heparin and the elu- 
tion profile from the heparin-Sepharose column are 
identical to those of chymase from human heart [5]. The 
purified enzyme has an apparent molecular mass of 30 
kDa on SDS-PAGE under reducing conditions, which 
is also identical to that of human chymase from skin 
and heart [5,6]. 
3.2. N-Terminal sequence 
The sequence of the 21 amino acid residues at the 
N-terminus of the purified enzyme was determined and 
Table II 
N-Terminal sequences of human tonsillar chymotrypsm-like protease 
and chymases from various sources 
1. Human tonsillar enzyme IIGGTESKPH SRPYMAYLEIV 
2. Human skin chymase” IIGGTESKPH SRPYMAYLEI'J 
3. Human heart chymaseh IIGGTECKPH SRPYMAYLEI ‘L' 
4. Rat chymase’ IIGGTiESRPH SRPYMAHLEI T 
5. Mouse chymase” IIGGVEARPH SRFYMAHLEI T 
6. Dog chymase’ IIGGTKSKPH SRPYMAHLEI L 
Refer to “(61. h[7], ‘[12]. “[13]. and ‘[14] 
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10 20 30 40 50 60 
ATCATCGGGGGCACAGAATCCAAGCCACATTCCCGCCCCTACATGGCCTACCTGGAAATT 
I IGGTESKPHSRPYMAYLEI 
70 80 90 100 110 120 
GTAACTTCCAACGGTCCCTCAAAATTTTGTGGTGGTTTCCTTATAAGACGGAACTTTGTG 
VTSNGPSKFCGGFLIRRNFV 
130 140 150 160 170 180 
CTGACGGCTGCTCATTGTGCAGGAAGGTCTATAACAGTCACCCTTGGAGCCCATAACATA 
LTAAHCAGRS ITVTLGAHNI 
190 200 210 220 230 240 
ACAGAGGAAGAAGACACATGGCAGAAGCTTGAGGTTATAAAGCAATTCCGTCATCCAAAA 
TEEEDTWQKLEVIKQFRHPK 
250 260 270 280 290 300 
TATAACACTTCTACTCTTCACCACGATATCATGTTACTAAAGTTG~GGAGAAAGCCAGC 
YNTSTLHHDIMLLKLKEKAS 
310 320 330 340 350 360 
CTGACCCTGGCTGTGGGGACACTCCCCTTCCCATCACAATTCAACTTTGTCCCACCTGGG 
LTLAVGTLPFPSQFNFVPPG 
370 380 390 400 410 420 
AGAATGTGCCGGGTGGCTGGCTGGGGAAGAACAGGTGTGTTGAAGCCGGGCTCAGACACT 
RMCRVAGW GRTGVLKPGSDT 
430 440 450 460 470 480 
CTGCAAGAGGTGAAGCTGAGACTCATGGATCCCCAGGCCTGCAGCCACTTCAGAGACTTT 
LQEVKLRLMDPQACSHFRDF 
490 500 510 520 530 540 
GACCACAATCTTCAGCTGTGTGTGGGCAATCCCAGGAAGACAAAATCTGCATTTAAGGGA 
DHNLQL CVGNPRKTKSAFKG 
550 560 570 580 590 600 
GACTCTGGGGGCCCTCTTCTGTGTGCTGGGGTGGCCCAGGGCATCGTATCCTATGGACGG 
DSGGPLLCAGVAQGIVSYGR 
610 620 630 640 650 660 
TCGGATGCAAAGCCCCCTGCTGTCTTCACCCGAATCTCTCCCATTACCGGCCCTGGATC~ 
SDAKPPAVFTRISHYRPWIN 
670 680 
CAGATCCTGCAGGCAAATTAA 
QILQAN* 
Ftg. 2DNA sequence and deduced amino actd sequence ofhumantonstllarchymotrypsin-like protease. The681 base cDNA was generated using 
primers DNA1 and DNA3 as hown m Fig. 1. lane 3. DNAs 1, 3and 4 represented in helegend for Fig. 1 are underlined. The asterisk indicates 
the termination codon. 
is shown in Table II, along with those of human skin 
and heart, as well as rat, mouse, and dog chymases. The 
amino acid sequence of human tonsillar chymotrypsin- 
like protease was identical to that of chymase from 
human skin [6], and that of chymase from human heart 
except for having Ser instead of Cys at the N-terminal 
7th position [5]. It was also similar to those of chymases 
from rat [12], mouse [13]. and dog [14]. 
3.3. Molecular cloning of chymase 
Fresh human tonsils were the source of mRNA. The 
extracted tonsils were immediately soaked in liquid ni- 
trogen, then mRNA was extracted in guanidine isothio- 
cyanate [ll]. The total RNA was further purified to 
poly(A) RNA by oligo-dT column chromatography. 
The mRNA (2.3 pug) was transcribed to cDNA by re- 
verse transcriptase, then the cDNA products were used 
for PCR. The PCR primers were selected as follows. 
The 5’ primer was ATCATCGGGGGCACAGAA- 
TCCA-AG (DNAl) from the N-terminal sequence 
IIGGTESK. The other 5’-primer was ATCATCG- 
GGGGCACAGAATGCAAG (DNA2) based on the 
N-terminal sequence of human heart chymase, in which 
the first 7th amino acid is Cys instead of Ser. 
The 3’ primers were TAATGGGAGATTCGGGTGA- 
AGAC (DNA4) for the VFTRISHY sequence of one of 
121 
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the most conserved regions of the chymase family, and 
TTAATTTGCCTGCAGATCTGGTT (DNA31 for the 
C-terminal sequence of human heart chymase [7]. A 
cDNA encoding the human tonsillar chymotrypsin-like 
enzyme was obtained by PCR using DNA1 as the 5’ 
primer and DNA3 or 4 as the 3’ primer, but no PCR 
product was amplified using DNA2 instead of DNA1 
as the 5’ primer as shown in Fig. 1. The sequences of 
the PCR products amplified using a combination of 
DNA1 and 3 and that of DNA 1 and 4 are the same. 
The length of the PCR product amplified using DNA1 
and 3 as primers was about 680 bp on 0.8% agarose. 
The product on the gel was excised, purified by resin, 
and the cDNA was blunt-ended and inserted in Ml3 
mpl0 at an H&II site. The deduced amino acid se- 
quence of the cloned cDNA comprises 214 amino acid 
residues, as shown in Fig. 2. The complete amino acid 
sequence determined was identical to that of chymase 
from human heart mast cells [7] except for the substitu- 
tion of Ser instead of Cys at the N-terminal 7th position, 
and the N-terminal 35 residues of the enzyme were iden- 
tical to those of human skin chymase previously re- 
ported [6]. The results suggest that a chymotrypsin-like 
protease isolated from human tonsils is a member of the 
human chymase family found in connective tissue mast 
cells. The results also support the finding that mast cells 
prepared from human tonsils are a useful source of 
human chymase and for studing the inhibition of hista- 
mine release from human mast cells by anti-allergic 
drugs, including chymase inhibitors [l-3]. 
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